In India there are certain plants that seem to have properties that provide protection from diabetes and diabetic complications. One of these plants is called amla or gooseberry...
Biodel, Inc. announced that it has submitted a new drug application to the U.S. Food and Drug Administration (FDA) for clearance to market of VIAject(R) as a treatment for diabetes. VIAjecta(R) is a formulation of recombinant human insulin that is designed to be absorbed into the blood faster than currently marketed rapid-acting insulin analogs. It is Biodel's most advanced product candidate and has been tested in more than 884 patients who participated in Phase 1, 2 and 3 clinical trials...
Novo Nordisk today announced that formal feedback from the United States Food and Drug Administration (FDA) regarding liraglutide is expected within weeks.
Liraglutide is the first once-daily human Glucagon-Like Peptide-1 (GLP-1) analogue developed for the treatment of type 2 diabetes...
It turned out, as well as being unable to control her blood sugar on a consistent basis, her blood sugar monitoring became unwieldy. Over time she was testing herself so often—fifteen or twenty times per day—her fingertips shriveled and toughened with scars.